Atrium extends Premier contract:
This article was originally published in Clinica
Executive Summary
Hudson, New Hampshire-based cardiovascular device developer Atrium Medical has extended its agreement with US group purchasing organisation Premier for thoracic drainage products by another three years. Under the terms of the dual-source contract, which took effect on March 1, Atrium will supply Premier's hospital members with products from its entire chest drainage device range including more recent additions such as the Express Mini 500 - a waterless, lightweight chest drainage system designed to be worn by the patient- and the Pneumostat chest drain valve.
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.